ID   ERI1_HUMAN              Reviewed;         349 AA.
AC   Q8IV48; A8K4U7; Q9NSX3;
DT   15-MAR-2004, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   22-JUL-2015, entry version 132.
DE   RecName: Full=3'-5' exoribonuclease 1;
DE            EC=3.1.-.-;
DE   AltName: Full=3'-5' exonuclease ERI1;
DE   AltName: Full=Eri-1 homolog;
DE   AltName: Full=Histone mRNA 3'-end-specific exoribonuclease;
DE   AltName: Full=Histone mRNA 3'-exonuclease 1;
DE   AltName: Full=Protein 3'hExo;
DE            Short=HEXO;
GN   Name=ERI1; Synonyms=3'EXO, THEX1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 2-23; 43-48; 53-67;
RP   161-172; 200-208; 225-237; 263-269 AND 284-291, FUNCTION, ENZYME
RP   REGULATION, ENZYME ACTIVITY, AND RNA-BINDING.
RX   PubMed=14536070; DOI=10.1016/S1097-2765(03)00278-8;
RA   Dominski Z., Yang X.-C., Kaygun H., Dadlez M., Marzluff W.F.;
RT   "A 3' exonuclease that specifically interacts with the 3' end of
RT   histone mRNA.";
RL   Mol. Cell 12:295-305(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT PRO-16.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   ENZYME ACTIVITY IN VITRO.
RX   PubMed=14961122; DOI=10.1038/nature02302;
RA   Kennedy S., Wang D., Ruvkun G.;
RT   "A conserved siRNA-degrading RNase negatively regulates RNA
RT   interference in C. elegans.";
RL   Nature 427:645-649(2004).
RN   [6]
RP   FUNCTION, IDENTIFICATION IN A TERNARY COMPLEX, ENZYME ACTIVITY,
RP   SUBCELLULAR LOCATION, MUTAGENESIS OF LYS-92; ARG-96; LYS-99; LYS-104;
RP   ARG-105; THY-109; THY-110; LYS-111; LYS-112; ASP-234; MET-235 AND
RP   ASP-298, AND RNA-BINDING.
RX   PubMed=16912046; DOI=10.1074/jbc.M602947200;
RA   Yang X.-C., Purdy M., Marzluff W.F., Dominski Z.;
RT   "Characterization of 3'hExo, a 3' exonuclease specifically interacting
RT   with the 3' end of histone mRNA.";
RL   J. Biol. Chem. 281:30447-30454(2006).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-62, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 123-322 IN COMPLEX WITH
RP   MAGNESIUM IONS AND AMP.
RX   PubMed=15451662; DOI=10.1016/j.jmb.2004.08.055;
RA   Cheng Y., Patel D.J.;
RT   "Crystallographic structure of the nuclease domain of 3'hExo, a DEDDh
RT   family member, bound to rAMP.";
RL   J. Mol. Biol. 343:305-312(2004).
CC   -!- FUNCTION: RNA exonuclease that binds to the 3'-end of histone
CC       mRNAs and degrades them, suggesting that it plays an essential
CC       role in histone mRNA decay after replication. A 2' and 3'-hydroxyl
CC       groups at the last nucleotide of the histone 3'-end is required
CC       for efficient degradation of RNA substrates. Also able to degrade
CC       the 3'-overhangs of short interfering RNAs (siRNAs) in vitro,
CC       suggesting a possible role as regulator of RNA interference
CC       (RNAi). Requires for binding the 5'-ACCCA-3' sequence present in
CC       stem-loop structure. Able to bind other mRNAs. Required for 5.8S
CC       rRNA 3'-end processing. Also binds to 5.8s ribosomal RNA. Binds
CC       with high affinity to the stem-loop structure of replication-
CC       dependent histone pre-mRNAs. {ECO:0000269|PubMed:14536070,
CC       ECO:0000269|PubMed:16912046}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC       Note=Binds 2 magnesium ions per subunit.;
CC   -!- ENZYME REGULATION: Although it can bind simultaneously with SLBP
CC       to the 3'-end of histone mRNA, the presence of SLBP prevents the
CC       exonuclease activity. {ECO:0000269|PubMed:14536070}.
CC   -!- SUBUNIT: Identified in a histone pre-mRNA complex, at least
CC       composed of ERI1, LSM11, SLBP, SNRPB, SYNCRIP and YBX1. Interacts
CC       in a cooperative manner with SLBP to the mature 3'-end of histone
CC       mRNAs (By similarity). Binds to 40S and 60S ribosomal subunits and
CC       to 80S assembled ribosomes. Found in a ternary complex with SLBP
CC       and the stem-loop structure of the 3'-end of histone mRNAs.
CC       {ECO:0000250, ECO:0000269|PubMed:15451662,
CC       ECO:0000269|PubMed:16912046}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:16912046}.
CC       Nucleus {ECO:0000269|PubMed:16912046}. Nucleus, nucleolus
CC       {ECO:0000269|PubMed:16912046}.
CC   -!- DOMAIN: The SAP domain is necessary for binding to the stem-loop
CC       structure of histone mRNAs and to form the ternary complex with
CC       SLBP, but not for 3'-end histone mRNA exonuclease activity.
CC   -!- SIMILARITY: Contains 1 exonuclease domain. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 SAP domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00186}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAB70871.2; Type=Erroneous termination; Positions=159; Note=Translated as Leu.; Evidence={ECO:0000305};
CC       Sequence=CAB70871.2; Type=Frameshift; Positions=117; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY310909; AAQ21219.1; -; mRNA.
DR   EMBL; AK291062; BAF83751.1; -; mRNA.
DR   EMBL; AL137679; CAB70871.2; ALT_SEQ; mRNA.
DR   EMBL; BC035279; AAH35279.1; -; mRNA.
DR   CCDS; CCDS5972.1; -.
DR   PIR; T46432; T46432.
DR   RefSeq; NP_699163.2; NM_153332.3.
DR   UniGene; Hs.20000; -.
DR   PDB; 1W0H; X-ray; 1.59 A; A=123-322.
DR   PDB; 1ZBH; X-ray; 3.00 A; A/B/C/D=51-349.
DR   PDB; 1ZBU; X-ray; 3.00 A; A/B/C/D=1-349.
DR   PDB; 4L8R; X-ray; 2.60 A; B/E=55-349.
DR   PDB; 4QOZ; X-ray; 2.30 A; B/E=55-349.
DR   PDBsum; 1W0H; -.
DR   PDBsum; 1ZBH; -.
DR   PDBsum; 1ZBU; -.
DR   PDBsum; 4L8R; -.
DR   PDBsum; 4QOZ; -.
DR   ProteinModelPortal; Q8IV48; -.
DR   SMR; Q8IV48; 60-349.
DR   BioGrid; 124718; 4.
DR   STRING; 9606.ENSP00000250263; -.
DR   PhosphoSite; Q8IV48; -.
DR   BioMuta; ERI1; -.
DR   DMDM; 45476938; -.
DR   MaxQB; Q8IV48; -.
DR   PaxDb; Q8IV48; -.
DR   PeptideAtlas; Q8IV48; -.
DR   PRIDE; Q8IV48; -.
DR   DNASU; 90459; -.
DR   Ensembl; ENST00000250263; ENSP00000250263; ENSG00000104626.
DR   Ensembl; ENST00000519292; ENSP00000430190; ENSG00000104626.
DR   Ensembl; ENST00000523898; ENSP00000429615; ENSG00000104626.
DR   GeneID; 90459; -.
DR   KEGG; hsa:90459; -.
DR   UCSC; uc003wsk.2; human.
DR   CTD; 90459; -.
DR   GeneCards; GC08P008900; -.
DR   HGNC; HGNC:23994; ERI1.
DR   HPA; CAB033838; -.
DR   HPA; HPA055548; -.
DR   HPA; HPA056074; -.
DR   MIM; 608739; gene.
DR   neXtProt; NX_Q8IV48; -.
DR   PharmGKB; PA164719226; -.
DR   eggNOG; COG5018; -.
DR   GeneTree; ENSGT00530000063205; -.
DR   HOGENOM; HOG000006635; -.
DR   HOVERGEN; HBG048925; -.
DR   KO; K18416; -.
DR   OMA; FLNIQCR; -.
DR   OrthoDB; EOG7BGHM2; -.
DR   PhylomeDB; Q8IV48; -.
DR   TreeFam; TF313449; -.
DR   EvolutionaryTrace; Q8IV48; -.
DR   GenomeRNAi; 90459; -.
DR   NextBio; 76770; -.
DR   PRO; PR:Q8IV48; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; Q8IV48; -.
DR   CleanEx; HS_ERI1; -.
DR   ExpressionAtlas; Q8IV48; baseline and differential.
DR   Genevisible; Q8IV48; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0071204; C:histone pre-mRNA 3'end processing complex; ISS:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0008408; F:3'-5' exonuclease activity; IDA:UniProtKB.
DR   GO; GO:0000175; F:3'-5'-exoribonuclease activity; IBA:GO_Central.
DR   GO; GO:0071207; F:histone pre-mRNA stem-loop binding; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0043022; F:ribosome binding; ISS:UniProtKB.
DR   GO; GO:0019843; F:rRNA binding; ISS:UniProtKB.
DR   GO; GO:0000738; P:DNA catabolic process, exonucleolytic; IBA:GO_Central.
DR   GO; GO:0000467; P:exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA); IBA:GO_Central.
DR   GO; GO:0031047; P:gene silencing by RNA; IEA:UniProtKB-KW.
DR   GO; GO:0031125; P:rRNA 3'-end processing; ISS:UniProtKB.
DR   Gene3D; 3.30.420.10; -; 1.
DR   InterPro; IPR006055; Exonuclease.
DR   InterPro; IPR013520; Exonuclease_RNaseT/DNA_pol3.
DR   InterPro; IPR012337; RNaseH-like_dom.
DR   InterPro; IPR003034; SAP_dom.
DR   Pfam; PF00929; RNase_T; 1.
DR   Pfam; PF02037; SAP; 1.
DR   SMART; SM00479; EXOIII; 1.
DR   SMART; SM00513; SAP; 1.
DR   SUPFAM; SSF53098; SSF53098; 1.
DR   PROSITE; PS50800; SAP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Cytoplasm; Direct protein sequencing;
KW   Exonuclease; Hydrolase; Magnesium; Metal-binding; Nuclease; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; RNA-binding;
KW   RNA-mediated gene silencing; rRNA processing.
FT   INIT_MET      1      1       Removed. {ECO:0000305|PubMed:14536070}.
FT   CHAIN         2    349       3'-5' exoribonuclease 1.
FT                                /FTId=PRO_0000187007.
FT   DOMAIN       76    110       SAP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00186}.
FT   DOMAIN      130    306       Exonuclease.
FT   ACT_SITE    136    136       Proton acceptor. {ECO:0000255}.
FT   ACT_SITE    293    293       Proton acceptor. {ECO:0000255}.
FT   METAL       134    134       Magnesium 1.
FT   METAL       134    134       Magnesium 2.
FT   METAL       136    136       Magnesium 1.
FT   METAL       234    234       Magnesium 2.
FT   METAL       298    298       Magnesium 1.
FT   BINDING     136    136       AMP. {ECO:0000269|PubMed:15451662}.
FT   BINDING     137    137       AMP; via amide nitrogen and carbonyl
FT                                oxygen. {ECO:0000269|PubMed:15451662}.
FT   BINDING     293    293       AMP. {ECO:0000269|PubMed:15451662}.
FT   MOD_RES      62     62       Phosphoserine.
FT                                {ECO:0000269|PubMed:19690332}.
FT   VARIANT      16     16       L -> P (in dbSNP:rs2288672).
FT                                {ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_018107.
FT   MUTAGEN      92     92       K->A: Does not inhibit RNA-binding to the
FT                                stem-loop structure. Does not inhibit
FT                                RNA-binding to the stem-loop structure,
FT                                when associated with A-104.
FT                                {ECO:0000269|PubMed:16912046}.
FT   MUTAGEN      96     96       R->A: Does not inhibit RNA-binding to the
FT                                stem-loop structure.
FT                                {ECO:0000269|PubMed:16912046}.
FT   MUTAGEN      99     99       K->A: Reduces slightly RNA-binding to the
FT                                stem-loop structure.
FT                                {ECO:0000269|PubMed:16912046}.
FT   MUTAGEN     104    104       K->A: Does not inhibit RNA-binding to the
FT                                stem-loop structure. Does not inhibit
FT                                RNA-binding to the stem-loop structure,
FT                                when associated with A-92.
FT                                {ECO:0000269|PubMed:16912046}.
FT   MUTAGEN     105    105       R->A: Inhibits RNA-binding to the stem-
FT                                loop structure.
FT                                {ECO:0000269|PubMed:16912046}.
FT   MUTAGEN     109    109       Y->A: Reduces slightly RNA-binding to the
FT                                stem-loop structure; when associated with
FT                                A-110. {ECO:0000269|PubMed:16912046}.
FT   MUTAGEN     110    110       Y->A: Reduces slightly RNA-binding to the
FT                                stem-loop structure; when associated with
FT                                A-109. {ECO:0000269|PubMed:16912046}.
FT   MUTAGEN     111    111       K->A: Reduces RNA-binding to the stem-
FT                                loop structure but not 3'-end histone
FT                                mRNA exonuclease activity; when
FT                                associated with A-112.
FT                                {ECO:0000269|PubMed:16912046}.
FT   MUTAGEN     112    112       K->A: Reduces RNA-binding to the stem-
FT                                loop structure but not 3'-end histone
FT                                mRNA exonuclease activity; when
FT                                associated with A-111.
FT                                {ECO:0000269|PubMed:16912046}.
FT   MUTAGEN     234    234       D->A: Inhibits 3'-end histone mRNA
FT                                exonuclease activity.
FT                                {ECO:0000269|PubMed:16912046}.
FT   MUTAGEN     235    235       M->A: Inhibits RNA-binding to the stem-
FT                                loop structure and 3'-end histone mRNA
FT                                exonuclease activity.
FT                                {ECO:0000269|PubMed:16912046}.
FT   MUTAGEN     298    298       D->A: Inhibits 3'-end histone mRNA
FT                                exonuclease activity.
FT                                {ECO:0000269|PubMed:16912046}.
FT   HELIX        47     49       {ECO:0000244|PDB:1ZBU}.
FT   TURN         50     52       {ECO:0000244|PDB:1ZBU}.
FT   STRAND       53     57       {ECO:0000244|PDB:1ZBU}.
FT   HELIX        64     77       {ECO:0000244|PDB:4QOZ}.
FT   HELIX        81     90       {ECO:0000244|PDB:4QOZ}.
FT   HELIX        99    114       {ECO:0000244|PDB:4QOZ}.
FT   STRAND      115    119       {ECO:0000244|PDB:1ZBU}.
FT   STRAND      126    132       {ECO:0000244|PDB:1W0H}.
FT   STRAND      151    160       {ECO:0000244|PDB:1W0H}.
FT   TURN        161    163       {ECO:0000244|PDB:1W0H}.
FT   STRAND      165    174       {ECO:0000244|PDB:1W0H}.
FT   STRAND      177    179       {ECO:0000244|PDB:1W0H}.
FT   HELIX       184    190       {ECO:0000244|PDB:1W0H}.
FT   HELIX       194    198       {ECO:0000244|PDB:1W0H}.
FT   STRAND      200    202       {ECO:0000244|PDB:1ZBU}.
FT   HELIX       203    216       {ECO:0000244|PDB:1W0H}.
FT   TURN        220    222       {ECO:0000244|PDB:1W0H}.
FT   STRAND      225    231       {ECO:0000244|PDB:1W0H}.
FT   TURN        232    235       {ECO:0000244|PDB:1W0H}.
FT   HELIX       236    246       {ECO:0000244|PDB:1W0H}.
FT   HELIX       252    254       {ECO:0000244|PDB:1W0H}.
FT   STRAND      255    259       {ECO:0000244|PDB:1W0H}.
FT   HELIX       260    268       {ECO:0000244|PDB:1W0H}.
FT   HELIX       272    274       {ECO:0000244|PDB:1W0H}.
FT   HELIX       277    283       {ECO:0000244|PDB:1W0H}.
FT   HELIX       295    311       {ECO:0000244|PDB:1W0H}.
FT   STRAND      320    323       {ECO:0000244|PDB:4QOZ}.
FT   STRAND      326    329       {ECO:0000244|PDB:4QOZ}.
FT   STRAND      332    334       {ECO:0000244|PDB:1ZBH}.
SQ   SEQUENCE   349 AA;  40064 MW;  D5837AA05F09410C CRC64;
     MEDPQSKEPA GEAVALALLE SPRPEGGEEP PRPSPEETQQ CKFDGQETKG SKFITSSASD
     FSDPVYKEIA ITNGCINRMS KEELRAKLSE FKLETRGVKD VLKKRLKNYY KKQKLMLKES
     NFADSYYDYI CIIDFEATCE EGNPPEFVHE IIEFPVVLLN THTLEIEDTF QQYVRPEINT
     QLSDFCISLT GITQDQVDRA DTFPQVLKKV IDWMKLKELG TKYKYSLLTD GSWDMSKFLN
     IQCQLSRLKY PPFAKKWINI RKSYGNFYKV PRSQTKLTIM LEKLGMDYDG RPHCGLDDSK
     NIARIAVRML QDGCELRINE KMHAGQLMSV SSSLPIEGTP PPQMPHFRK
//
